Press Release: ACUVUE OASYS® Brand Contact Lenses 1-Day with HydraLuxe™



ACUVUE OASYS® Brand Contact Lenses 1-Day with HydraLuxe™ Technology help support the natural tear film and was preferred overall to the competition in a head-to-head study1

JACKSONVILLE, Fla., September 10, 2015: Johnson & Johnson Vision Care, Inc. announced the launch of a new lens with a tear-infused design, ACUVUE OASYS® Brand Contact Lenses 1-Day with HydraLuxe™ Technology, to provide excellent comfort and vision throughout a day full of activities.

For a majority of contact lens wearers (59 percent)2 , contact lens performance declines throughout the day. This rate of decline correlates with the number of activities the contact lens wearer performs in a day, and research shows that a full day of activities can lead to eye fatigue or the feeling of tired eyes.

“We honed in on the human insight that patients need contact lenses that can keep up with the daily demands of today’s modern life,” said Millicent Knight, OD, vice president of professional affairs, Johnson & Johnson Vision Care, Inc. North America. “This includes looking at computers, smartphones, or even living in air-conditioned buildings. Each one is a potential contributor to destabilizing the natural tear film throughout the course of the day, causing a decline in contact lens performance.”3

ACUVUE OASYS® 1-Day with HydraLuxe™ Technology is designed to help keep contact lens wearers comfortable throughout their demanding days. There are four key technology advances to help address this unmet patient need:

  • Tear-infused material, complementing the natural tear film with an enhanced network of tear-like molecules, that integrates with contact lens wearers’ own tear film each day
  • Electrolyte-balanced packaging solution to mimic human tears
  • Enlarged optics to help wearers to see clearly even when their pupils may be enlarged due to low-light
  • Increased lens diameter to ensure full corneal limbus coverage during blinking.

“Tears are the key to this innovation,” said Peter Shen, vice president, Worldwide Research & Development, Johnson & Johnson Vision Care, Inc. “We know tears are essential to provide a smooth optical surface, provide oxygen to the cornea, and moisturize and lubricate the eyes to facilitate natural blinking. The tear-like molecules in ACUVUE OASYS® 1-Day with HydraLuxe™ Technology mimic mucins, which lubricate and moisturize the eye and help support a stable tear film even through our most demanding days.”

ACUVUE OASYS® 1-Day with HydraLuxe™ Technology works consistently throughout the day to help support a stable tear film. In a head-to-head comparison with Dailies Total1 ® in 119 people who wore both lenses for a week, ACUVUE OASYS® 1-Day with HydraLuxe™ Technology was preferred 2:1 overall, with excellent performance in comfort, vision and handling, including ease of removal.1 The ACUVUE OASYS® 1-Day has the highest level of UV blocking available in a contact lens to help protect the eye from the transmission of the sun’s harmful rays.†‡ ACUVUE OASYS® 1-Day with HydraLuxe™ Technology will launch worldwide beginning in 2016.

A New Design to Provide Superior Experience

They EYE-INSPIRED™ Design behind ACUVUE OASYS® 1-Day with HydraLuxe™ Technology was to develop a tear-like lens, not simply water based, in order to help support a patient’s tear film each day. Unlike water-gradient designs, a tear-infused contact lens is smoother at the surface, has a uniform composition throughout the lens and has consistent performance over time. Additionally, the lens was designed with an increased diameter to ensure full corneal limbus coverage during blinking and includes enlarged optics to help cover larger pupils in low lighting conditions.


For more than 30 years, Johnson & Johnson Vision Care, Inc. has focused exclusively on improving vision through quality contact lenses, never compromising on its goal to create technologies that make meaningful differences in people’s lives.

A deep understanding of patient lifestyle needs as well as those of eye care professionals has driven R&D to create innovative solutions designed to complement the natural function of the eye. By developing contact lenses based on a deep understanding of how the eye works, the ACUVUE® Brand strives to maximize the eye’s natural wellbeing during contact lens wear, and give patients and eye care professionals an exceptional experience. About Johnson & Johnson Vision Care, Inc. Johnson & Johnson Vision Care, Inc. is committed to creating life-long solutions to vision care needs. Since the ACUVUE® Brand made its debut in 1987 as the world’s first disposable soft contact lens, the company has repeatedly brought innovative, quality, and scientific advancements to the industry. Headquartered in Jacksonville, Florida, the company has some 3,000 employees worldwide. For more information, visit

# # #

Important Information for Contact Lens Wearers: ACUVUE® Brand Contact Lenses are available by prescription only for vision correction. An eye care professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing contact lenses. To help avoid these problems, follow the wear and replacement schedule and the lens care instructions provided by your eye doctor. Do not wear contact lenses if you have an eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. If one of these conditions occurs, contact your eye doctor immediately. For more information on proper wear, care and safety, talk to your eye care professional and ask for a Patient Instruction Guide, call 1-800-843-2020 or visit

†Helps protect against transmission of harmful UV radiation to the cornea and into the eye.

‡WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

ACUVUE OASYS® with HydraLuxe™ Technology, 1-Day ACUVUE® MOIST Brand Contact Lenses and EYE-INSPIRED™ Design are registered trademarks of Johnson & Johnson Vision Care, Inc.

Third party trademarks used herein are trademarks of their respective owners.

For further information, contact:

Donna Lorenson
Johnson & Johnson


(1) n=119, 4-7 days of 1-day wear. Preference results are among those with a preference.

(2) Mathews K. et al. Exploring Variability in Soft Contact Lens Performance throughout the Day. Abstract. 2015 American Academy of Optometry (AAO) Annual Meeting. October 8, 2015.

(3) Craig JP, Willcox MDP, Argueso P, et al. The TFOS International Workshop on Contact Lens Discomfort: Report of the Contact Lens Interaction with the Tear Film Subcommittee. Invest Ophthalmol Vis Sci. 2013; 54 (11):TFOS123-TFOS156.

About Matt Geller

Matthew Geller
Dr. Matt Geller is a technology entrepreneur with a track record of developing successful online platforms to solve problems in the healthcare space. Matt is an optometrist in San Diego and is the founder of, and the co-founder of!

Leave a Reply

Send this to a friend